Aciclovir - CAS 59277-89-3
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
Aciclovir
Catalog Number:
B0084-187262
Synonyms:
Acyclovir
CAS Number:
59277-89-3
Description:
Aciclovir is a synthetic nucleoside analogue active against herpesviruses.It is primarily used for the treatment of herpes simplex virus infections, chickenpox and shingles.
Molecular Weight:
225.2
Molecular Formula:
C8H11N5O3
COA:
Inquire
MSDS:
Inquire
Targets:
HSV
Catalog Number Size Price Stock Quantity
B0084-187262 25 g $249 In stock
Bulk Inquiry
Chemical Structure
CAS 59277-89-3 Aciclovir

Related HSV Products


CAS 69123-90-6 Fiacitabine

Fiacitabine
(CAS: 69123-90-6)

Fiacitabine is a selective inhibitior of DNA replication of herpes simplex virus(HSV). It was active at much lower concentrations than arabinosylcytosine, iodod...

CAS 124832-26-4 Valacyclovir

Valacyclovir
(CAS: 124832-26-4)

Valaciclovir is an antiviral drug used in the management of herpes simplex, herpes zoster, and herpes B.

CAS 59277-89-3 Aciclovir

Aciclovir
(CAS: 59277-89-3)

Aciclovir is a synthetic nucleoside analogue active against herpesviruses.It is primarily used for the treatment of herpes simplex virus infections, chickenpox ...

CAS 82410-32-0 Ganciclovir

Ganciclovir
(CAS: 82410-32-0)

Ganciclovir is an antiviral drug for feline herpesvirus type-1 with IC50 of 5.2 μM.

CAS 348086-71-5 BAY-57-1293

BAY-57-1293
(CAS: 348086-71-5)

BAY 57-1293 represents a new class of potent inhibitors of herpes simplex virus (HSV) that target the virus helicase primase complex. Potent helicase-primase in...

CAS 124832-27-5 Valacyclovir hydrochloride

Valacyclovir hydrochloride
(CAS: 124832-27-5)

Valaciclovir HCl is an antiviral drug used in the management of herpes simplex, herpes zoster, and herpes B.

CAS 5536-17-4 Vidarabine

Vidarabine
(CAS: 5536-17-4)

Vidarabine is a nucleoside antibiotic isolated from Streptomyces antibioticus, which is active against herpes simplex and varicella zoster viruses. It has some ...

WAY 150138
(CAS: 273388-09-3)

WAY 150138, belonging to a novel group of thiourea compounds, can cause the inhibition of the herpes simplex virus.

CAS 104227-87-4 Famciclovir

Famciclovir
(CAS: 104227-87-4)

Famciclovir(Famvir) is a guanine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). I...

CAS 39809-25-1 Penciclovir

Penciclovir
(CAS: 39809-25-1)

Penciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirusinfections. It is a nucleoside analogue which exhibits low toxic...

CAS 54-42-2 Idoxuridine

Idoxuridine
(CAS: 54-42-2)

It is a nucleoside analogue, a modified form of deoxyuridine, similar enough to be incorporated into viral DNA replication, but the iodine atom added to the ura...

CAS 661-19-8 Docosanol

Docosanol
(CAS: 661-19-8)

Docosanol is a saturated fatty alcoholused traditionally as an emollient, emulsifier, and thickener in cosmetics, nutritional supplement.

Reference Reading


1.Study of Antiherpetic Efficiency of Phosphite of Acycloguanosine Ableto Over come the Barrier of Resistance to Acyclovir.
Andronova VL1, Jasko MV2, Kukhanova MK2, Galegov GA2, Skoblov YS3, Kochetkov SN2. Acta Naturae. 2016 Jan-Mar;8(1):74-81.
As has been shown previously, phosphite of acycloguanosine (Hp-ACG) exhibits equal efficacy against ACV-sensitive and ACV-resistant HSV-1 strains in cell culture. Intraperitoneal administration of Hp-ACG to model mice with herpetic encephalitis caused by HSV-1 infection was shown to be effective in protecting against death. In the present work, we continue the study of the antiviral efficiency of Hp-ACG against HSV administered non-invasively; namely in vivo, orally and in the form of ointment formulations. It has been first shown that oral administration of Hp-ACG twice daily for five days prevents systemic infection in mice caused by HSV-1. Mortality in the control group of animals was 57%. Administration of Hp-ACG at doses of 600, 800 and 1,000 mg/kg per day significantly increased the survival and median day of death of the animals compared to the placebo-treated control group. A comparative evaluation of the therapeutic efficacy parameters of polyethylene glycol-based ACV ointment and Hp-ACG ointment was carried out after a 5-day course in the model of an experimental cutaneous infection of HSV-1 in guinea pigs.
2.Thiolated Cyclodextrin: Development of a Mucoadhesive Vaginal Delivery System for Acyclovir.
Ijaz M1, Griessinger JA2, Mahmood A1, Laffleur F1, Bernkop-Schnürch A3. J Pharm Sci. 2016 May;105(5):1714-20. doi: 10.1016/j.xphs.2016.03.009.
The objective of this study was the development of a mucoadhesive vaginal delivery system for acyclovir (Acv). Sodium-per-iodate (NaIO4) was used to introduce aldehyde substructures into beta-cyclodextrin (β-CD) by oxidative cleavage of vicinal diol bonds. Cysteamine was covalently attached to β-CD-CHO via reductive amination. Ellman's reagent was utilized for quantification of free thiol groups attached and resazurin assay was used for cytotoxicity studies. Mucoadhesive properties were evaluated on porcine vaginal mucosa in comparison to intestinal mucosa. Quantification of thiol groups revealed 851.84 ± 107, 1040.44 ± 132, and 1563.72 ± 171 μmol/g of free thiol groups attached to the β-CD-SH851, β-CD-SH1040, and β-CD-SH1563, respectively. β-CD-SH derivatives at concentrations of 0.5% (m/v) did not show significant reduction of viability of Caco-2 cells within 24 h. Furthermore, water solubility of β-CD-SH1563 was improved 7.6-fold in comparison to unmodified β-CD.